Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?
- 1 May 2000
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 15 (5 (Suppl.)) , E141-E151
- https://doi.org/10.1046/j.1440-1746.2000.02116.x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C?Journal of Gastroenterology and Hepatology, 1999
- Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis CJournal of Medical Virology, 1998
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type CJournal of Hepatology, 1997
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- Interferon treatment of cirrhotic patients with chronic hepatitis CJournal of Viral Hepatitis, 1997
- Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serumJournal of Hepatology, 1996
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and durationHepatology, 1996
- Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivoHepatology, 1996
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996
- Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.Gut, 1995